Cell & gene therapies are used to treat both rare and common diseases. While gene therapy involves the transfer of genetic material, usually within a virus for uptake into diseased cells, cell therapy involves the transfer of genetically altered cells into a patient.
The global market for Cell and Gene Therapy Solutions is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Cell and Gene Therapy Solutions market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Cell and Gene Therapy Solutions market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Cell and Gene Therapy Solutions market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Cell and Gene Therapy Solutions market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Cell and Gene Therapy Solutions players cover Bluebird Bio, Sarepta Therapeutics, Solid Biosciences, Novartis and Biomarin Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Cell and Gene Therapy Solutions market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Cell and Gene Therapy Solutions market, with both quantitative and qualitative data, to help readers understand how the Cell and Gene Therapy Solutions market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Cell and Gene Therapy Solutions market and forecasts the market size by Type (Stem Cell Therapy, Gene Therapy and Other), by Application (Neurological Diseases, Cancer and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Stem Cell Therapy
Gene Therapy
Other
Segmentation by application
Neurological Diseases
Cancer
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Bluebird Bio
Sarepta Therapeutics
Solid Biosciences
Novartis
Biomarin Pharmaceutical
Uniqure
Spark Therapeutics
Alaunos Therapeutics
Homology Medicines
Biogen
Legend Biotech
CARsgen
Chapter Introduction
Chapter 1: Scope of Cell and Gene Therapy Solutions, Research Methodology, etc.
Chapter 2: Executive Summary, global Cell and Gene Therapy Solutions market size and CAGR, Cell and Gene Therapy Solutions market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Cell and Gene Therapy Solutions revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Cell and Gene Therapy Solutions revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Cell and Gene Therapy Solutions market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Bluebird Bio, Sarepta Therapeutics, Solid Biosciences, Novartis, Biomarin Pharmaceutical, Uniqure, Spark Therapeutics, Alaunos Therapeutics and Homology Medicines, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy Solutions Market Size 2017-2028
2.1.2 Cell and Gene Therapy Solutions Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Cell and Gene Therapy Solutions Segment by Type
2.2.1 Stem Cell Therapy
2.2.2 Gene Therapy
2.2.3 Other
2.3 Cell and Gene Therapy Solutions Market Size by Type
2.3.1 Cell and Gene Therapy Solutions Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Cell and Gene Therapy Solutions Market Size Market Share by Type (2017-2022)
2.4 Cell and Gene Therapy Solutions Segment by Application
2.4.1 Neurological Diseases
2.4.2 Cancer
2.4.3 Other
2.5 Cell and Gene Therapy Solutions Market Size by Application
2.5.1 Cell and Gene Therapy Solutions Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Cell and Gene Therapy Solutions Market Size Market Share by Application (2017-2022)
3 Cell and Gene Therapy Solutions Market Size by Player
3.1 Cell and Gene Therapy Solutions Market Size Market Share by Players
3.1.1 Global Cell and Gene Therapy Solutions Revenue by Players (2020-2022)
3.1.2 Global Cell and Gene Therapy Solutions Revenue Market Share by Players (2020-2022)
3.2 Global Cell and Gene Therapy Solutions Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cell and Gene Therapy Solutions by Regions
4.1 Cell and Gene Therapy Solutions Market Size by Regions (2017-2022)
4.2 Americas Cell and Gene Therapy Solutions Market Size Growth (2017-2022)
4.3 APAC Cell and Gene Therapy Solutions Market Size Growth (2017-2022)
4.4 Europe Cell and Gene Therapy Solutions Market Size Growth (2017-2022)
4.5 Middle East & Africa Cell and Gene Therapy Solutions Market Size Growth (2017-2022)
5 Americas
5.1 Americas Cell and Gene Therapy Solutions Market Size by Country (2017-2022)
5.2 Americas Cell and Gene Therapy Solutions Market Size by Type (2017-2022)
5.3 Americas Cell and Gene Therapy Solutions Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell and Gene Therapy Solutions Market Size by Region (2017-2022)
6.2 APAC Cell and Gene Therapy Solutions Market Size by Type (2017-2022)
6.3 APAC Cell and Gene Therapy Solutions Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cell and Gene Therapy Solutions by Country (2017-2022)
7.2 Europe Cell and Gene Therapy Solutions Market Size by Type (2017-2022)
7.3 Europe Cell and Gene Therapy Solutions Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cell and Gene Therapy Solutions by Region (2017-2022)
8.2 Middle East & Africa Cell and Gene Therapy Solutions Market Size by Type (2017-2022)
8.3 Middle East & Africa Cell and Gene Therapy Solutions Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cell and Gene Therapy Solutions Market Forecast
10.1 Global Cell and Gene Therapy Solutions Forecast by Regions (2023-2028)
10.1.1 Global Cell and Gene Therapy Solutions Forecast by Regions (2023-2028)
10.1.2 Americas Cell and Gene Therapy Solutions Forecast
10.1.3 APAC Cell and Gene Therapy Solutions Forecast
10.1.4 Europe Cell and Gene Therapy Solutions Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy Solutions Forecast
10.2 Americas Cell and Gene Therapy Solutions Forecast by Country (2023-2028)
10.2.1 United States Cell and Gene Therapy Solutions Market Forecast
10.2.2 Canada Cell and Gene Therapy Solutions Market Forecast
10.2.3 Mexico Cell and Gene Therapy Solutions Market Forecast
10.2.4 Brazil Cell and Gene Therapy Solutions Market Forecast
10.3 APAC Cell and Gene Therapy Solutions Forecast by Region (2023-2028)
10.3.1 China Cell and Gene Therapy Solutions Market Forecast
10.3.2 Japan Cell and Gene Therapy Solutions Market Forecast
10.3.3 Korea Cell and Gene Therapy Solutions Market Forecast
10.3.4 Southeast Asia Cell and Gene Therapy Solutions Market Forecast
10.3.5 India Cell and Gene Therapy Solutions Market Forecast
10.3.6 Australia Cell and Gene Therapy Solutions Market Forecast
10.4 Europe Cell and Gene Therapy Solutions Forecast by Country (2023-2028)
10.4.1 Germany Cell and Gene Therapy Solutions Market Forecast
10.4.2 France Cell and Gene Therapy Solutions Market Forecast
10.4.3 UK Cell and Gene Therapy Solutions Market Forecast
10.4.4 Italy Cell and Gene Therapy Solutions Market Forecast
10.4.5 Russia Cell and Gene Therapy Solutions Market Forecast
10.5 Middle East & Africa Cell and Gene Therapy Solutions Forecast by Region (2023-2028)
10.5.1 Egypt Cell and Gene Therapy Solutions Market Forecast
10.5.2 South Africa Cell and Gene Therapy Solutions Market Forecast
10.5.3 Israel Cell and Gene Therapy Solutions Market Forecast
10.5.4 Turkey Cell and Gene Therapy Solutions Market Forecast
10.5.5 GCC Countries Cell and Gene Therapy Solutions Market Forecast
10.6 Global Cell and Gene Therapy Solutions Forecast by Type (2023-2028)
10.7 Global Cell and Gene Therapy Solutions Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Bluebird Bio
11.1.1 Bluebird Bio Company Information
11.1.2 Bluebird Bio Cell and Gene Therapy Solutions Product Offered
11.1.3 Bluebird Bio Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Bluebird Bio Main Business Overview
11.1.5 Bluebird Bio Latest Developments
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Information
11.2.2 Sarepta Therapeutics Cell and Gene Therapy Solutions Product Offered
11.2.3 Sarepta Therapeutics Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Sarepta Therapeutics Main Business Overview
11.2.5 Sarepta Therapeutics Latest Developments
11.3 Solid Biosciences
11.3.1 Solid Biosciences Company Information
11.3.2 Solid Biosciences Cell and Gene Therapy Solutions Product Offered
11.3.3 Solid Biosciences Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Solid Biosciences Main Business Overview
11.3.5 Solid Biosciences Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Cell and Gene Therapy Solutions Product Offered
11.4.3 Novartis Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Biomarin Pharmaceutical
11.5.1 Biomarin Pharmaceutical Company Information
11.5.2 Biomarin Pharmaceutical Cell and Gene Therapy Solutions Product Offered
11.5.3 Biomarin Pharmaceutical Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Biomarin Pharmaceutical Main Business Overview
11.5.5 Biomarin Pharmaceutical Latest Developments
11.6 Uniqure
11.6.1 Uniqure Company Information
11.6.2 Uniqure Cell and Gene Therapy Solutions Product Offered
11.6.3 Uniqure Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Uniqure Main Business Overview
11.6.5 Uniqure Latest Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics Cell and Gene Therapy Solutions Product Offered
11.7.3 Spark Therapeutics Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Spark Therapeutics Main Business Overview
11.7.5 Spark Therapeutics Latest Developments
11.8 Alaunos Therapeutics
11.8.1 Alaunos Therapeutics Company Information
11.8.2 Alaunos Therapeutics Cell and Gene Therapy Solutions Product Offered
11.8.3 Alaunos Therapeutics Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Alaunos Therapeutics Main Business Overview
11.8.5 Alaunos Therapeutics Latest Developments
11.9 Homology Medicines
11.9.1 Homology Medicines Company Information
11.9.2 Homology Medicines Cell and Gene Therapy Solutions Product Offered
11.9.3 Homology Medicines Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Homology Medicines Main Business Overview
11.9.5 Homology Medicines Latest Developments
11.10 Biogen
11.10.1 Biogen Company Information
11.10.2 Biogen Cell and Gene Therapy Solutions Product Offered
11.10.3 Biogen Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Biogen Main Business Overview
11.10.5 Biogen Latest Developments
11.11 Legend Biotech
11.11.1 Legend Biotech Company Information
11.11.2 Legend Biotech Cell and Gene Therapy Solutions Product Offered
11.11.3 Legend Biotech Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Legend Biotech Main Business Overview
11.11.5 Legend Biotech Latest Developments
11.12 CARsgen
11.12.1 CARsgen Company Information
11.12.2 CARsgen Cell and Gene Therapy Solutions Product Offered
11.12.3 CARsgen Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 CARsgen Main Business Overview
11.12.5 CARsgen Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Cell and Gene Therapy Solutions Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Stem Cell Therapy
Table 3. Major Players of Gene Therapy
Table 4. Major Players of Other
Table 5. Cell and Gene Therapy Solutions Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Cell and Gene Therapy Solutions Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Cell and Gene Therapy Solutions Market Size Market Share by Type (2017-2022)
Table 8. Cell and Gene Therapy Solutions Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Cell and Gene Therapy Solutions Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Cell and Gene Therapy Solutions Market Size Market Share by Application (2017-2022)
Table 11. Global Cell and Gene Therapy Solutions Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Cell and Gene Therapy Solutions Revenue Market Share by Player (2020-2022)
Table 13. Cell and Gene Therapy Solutions Key Players Head office and Products Offered
Table 14. Cell and Gene Therapy Solutions Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cell and Gene Therapy Solutions Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Cell and Gene Therapy Solutions Market Size Market Share by Regions (2017-2022)
Table 19. Americas Cell and Gene Therapy Solutions Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Cell and Gene Therapy Solutions Market Size Market Share by Country (2017-2022)
Table 21. Americas Cell and Gene Therapy Solutions Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Cell and Gene Therapy Solutions Market Size Market Share by Type (2017-2022)
Table 23. Americas Cell and Gene Therapy Solutions Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Cell and Gene Therapy Solutions Market Size Market Share by Application (2017-2022)
Table 25. APAC Cell and Gene Therapy Solutions Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Cell and Gene Therapy Solutions Market Size Market Share by Region (2017-2022)
Table 27. APAC Cell and Gene Therapy Solutions Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Cell and Gene Therapy Solutions Market Size Market Share by Type (2017-2022)
Table 29. APAC Cell and Gene Therapy Solutions Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Cell and Gene Therapy Solutions Market Size Market Share by Application (2017-2022)
Table 31. Europe Cell and Gene Therapy Solutions Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Cell and Gene Therapy Solutions Market Size Market Share by Country (2017-2022)
Table 33. Europe Cell and Gene Therapy Solutions Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Cell and Gene Therapy Solutions Market Size Market Share by Type (2017-2022)
Table 35. Europe Cell and Gene Therapy Solutions Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Cell and Gene Therapy Solutions Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Cell and Gene Therapy Solutions Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Cell and Gene Therapy Solutions Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Cell and Gene Therapy Solutions Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Cell and Gene Therapy Solutions Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Cell and Gene Therapy Solutions Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Cell and Gene Therapy Solutions Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy Solutions
Table 44. Key Market Challenges & Risks of Cell and Gene Therapy Solutions
Table 45. Key Industry Trends of Cell and Gene Therapy Solutions
Table 46. Global Cell and Gene Therapy Solutions Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Cell and Gene Therapy Solutions Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Cell and Gene Therapy Solutions Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Cell and Gene Therapy Solutions Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Cell and Gene Therapy Solutions Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Cell and Gene Therapy Solutions Market Size Market Share Forecast by Application (2023-2028)
Table 52. Bluebird Bio Details, Company Type, Cell and Gene Therapy Solutions Area Served and Its Competitors
Table 53. Bluebird Bio Cell and Gene Therapy Solutions Product Offered
Table 54. Bluebird Bio Cell and Gene Therapy Solutions Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Bluebird Bio Main Business
Table 56. Bluebird Bio Latest Developments
Table 57. Sarepta Therapeutics Details, Company Type, Cell and Gene Therapy Solutions Area Served and Its Competitors
Table 58. Sarepta Therapeutics Cell and Gene Therapy Solutions Product Offered
Table 59. Sarepta Therapeutics Main Business
Table 60. Sarepta Therapeutics Cell and Gene Therapy Solutions Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Sarepta Therapeutics Latest Developments
Table 62. Solid Biosciences Details, Company Type, Cell and Gene Therapy Solutions Area Served and Its Competitors
Table 63. Solid Biosciences Cell and Gene Therapy Solutions Product Offered
Table 64. Solid Biosciences Main Business
Table 65. Solid Biosciences Cell and Gene Therapy Solutions Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Solid Biosciences Latest Developments
Table 67. Novartis Details, Company Type, Cell and Gene Therapy Solutions Area Served and Its Competitors
Table 68. Novartis Cell and Gene Therapy Solutions Product Offered
Table 69. Novartis Main Business
Table 70. Novartis Cell and Gene Therapy Solutions Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Novartis Latest Developments
Table 72. Biomarin Pharmaceutical Details, Company Type, Cell and Gene Therapy Solutions Area Served and Its Competitors
Table 73. Biomarin Pharmaceutical Cell and Gene Therapy Solutions Product Offered
Table 74. Biomarin Pharmaceutical Main Business
Table 75. Biomarin Pharmaceutical Cell and Gene Therapy Solutions Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Biomarin Pharmaceutical Latest Developments
Table 77. Uniqure Details, Company Type, Cell and Gene Therapy Solutions Area Served and Its Competitors
Table 78. Uniqure Cell and Gene Therapy Solutions Product Offered
Table 79. Uniqure Main Business
Table 80. Uniqure Cell and Gene Therapy Solutions Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Uniqure Latest Developments
Table 82. Spark Therapeutics Details, Company Type, Cell and Gene Therapy Solutions Area Served and Its Competitors
Table 83. Spark Therapeutics Cell and Gene Therapy Solutions Product Offered
Table 84. Spark Therapeutics Main Business
Table 85. Spark Therapeutics Cell and Gene Therapy Solutions Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Spark Therapeutics Latest Developments
Table 87. Alaunos Therapeutics Details, Company Type, Cell and Gene Therapy Solutions Area Served and Its Competitors
Table 88. Alaunos Therapeutics Cell and Gene Therapy Solutions Product Offered
Table 89. Alaunos Therapeutics Main Business
Table 90. Alaunos Therapeutics Cell and Gene Therapy Solutions Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Alaunos Therapeutics Latest Developments
Table 92. Homology Medicines Details, Company Type, Cell and Gene Therapy Solutions Area Served and Its Competitors
Table 93. Homology Medicines Cell and Gene Therapy Solutions Product Offered
Table 94. Homology Medicines Main Business
Table 95. Homology Medicines Cell and Gene Therapy Solutions Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Homology Medicines Latest Developments
Table 97. Biogen Details, Company Type, Cell and Gene Therapy Solutions Area Served and Its Competitors
Table 98. Biogen Cell and Gene Therapy Solutions Product Offered
Table 99. Biogen Main Business
Table 100. Biogen Cell and Gene Therapy Solutions Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Biogen Latest Developments
Table 102. Legend Biotech Details, Company Type, Cell and Gene Therapy Solutions Area Served and Its Competitors
Table 103. Legend Biotech Cell and Gene Therapy Solutions Product Offered
Table 104. Legend Biotech Cell and Gene Therapy Solutions Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Legend Biotech Main Business
Table 106. Legend Biotech Latest Developments
Table 107. CARsgen Details, Company Type, Cell and Gene Therapy Solutions Area Served and Its Competitors
Table 108. CARsgen Cell and Gene Therapy Solutions Product Offered
Table 109. CARsgen Main Business
Table 110. CARsgen Cell and Gene Therapy Solutions Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. CARsgen Latest Developments
List of Figures
List of Figures
Figure 1. Cell and Gene Therapy Solutions Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Gene Therapy Solutions Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Cell and Gene Therapy Solutions Market Size Market Share by Type in 2021
Figure 7. Cell and Gene Therapy Solutions in Neurological Diseases
Figure 8. Global Cell and Gene Therapy Solutions Market: Neurological Diseases (2017-2022) & ($ Millions)
Figure 9. Cell and Gene Therapy Solutions in Cancer
Figure 10. Global Cell and Gene Therapy Solutions Market: Cancer (2017-2022) & ($ Millions)
Figure 11. Cell and Gene Therapy Solutions in Other
Figure 12. Global Cell and Gene Therapy Solutions Market: Other (2017-2022) & ($ Millions)
Figure 13. Global Cell and Gene Therapy Solutions Market Size Market Share by Application in 2021
Figure 14. Global Cell and Gene Therapy Solutions Revenue Market Share by Player in 2021
Figure 15. Global Cell and Gene Therapy Solutions Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Cell and Gene Therapy Solutions Market Size 2017-2022 ($ Millions)
Figure 17. APAC Cell and Gene Therapy Solutions Market Size 2017-2022 ($ Millions)
Figure 18. Europe Cell and Gene Therapy Solutions Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Cell and Gene Therapy Solutions Market Size 2017-2022 ($ Millions)
Figure 20. Americas Cell and Gene Therapy Solutions Value Market Share by Country in 2021
Figure 21. Americas Cell and Gene Therapy Solutions Consumption Market Share by Type in 2021
Figure 22. Americas Cell and Gene Therapy Solutions Market Size Market Share by Application in 2021
Figure 23. United States Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Cell and Gene Therapy Solutions Market Size Market Share by Region in 2021
Figure 28. APAC Cell and Gene Therapy Solutions Market Size Market Share by Application in 2021
Figure 29. China Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Cell and Gene Therapy Solutions Market Size Market Share by Country in 2021
Figure 36. Europe Cell and Gene Therapy Solutions Market Size Market Share by Type in 2021
Figure 37. Europe Cell and Gene Therapy Solutions Market Size Market Share by Application in 2021
Figure 38. Germany Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Cell and Gene Therapy Solutions Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Cell and Gene Therapy Solutions Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Cell and Gene Therapy Solutions Market Size Market Share by Application in 2021
Figure 46. Egypt Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Cell and Gene Therapy Solutions Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 52. APAC Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 53. Europe Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 55. United States Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 56. Canada Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 59. China Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 60. Japan Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 61. Korea Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 63. India Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 64. Australia Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 65. Germany Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 66. France Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 67. UK Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 68. Italy Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 69. Russia Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 70. Spain Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 73. Israel Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Cell and Gene Therapy Solutions Market Size 2023-2028 ($ Millions)
Reason to Buy